News

CSHL’s learning center adopts the Agilent 2100 Bioanalyzer system to teach high school students and teachers how to analyze DNA.

Phase I clinical trial for genetic eye disease also shows visual benefit for daily activities.

5th Annual Stem Cell Action awards presented at 2009 World Stem Cell Summit in Baltimore.

Tufts researchers report that STAT3 could become a target for cancer therapy, specifically in Glioblastoma multiforme.

Five research projects to receive total of more than $400,000 in RNAi screening tools.

Redesigned Organic Synthesis Knowledge Area within Prous Science Integrity allows researchers to directly retrieve intermediates and reagents.

The new technique is developed to extract DNA and RNA from small or heavily contaminated samples.

Researchers find that the FOXC1 gene contributes to Dandy-Walker malformation, a brain defect that occurs in 1 of every 5,000 births.

The xCELLigence RTCA System from Roche Applied Science allows for label-free, continuous monitoring of cell phenotypic changes using electrical impedance as readout. The interaction of cells with the electronic biosensors leads to the generation of a cell-electrode impedance response which indicates the status of the cells in terms of cell number, cell viability, cell morphology and cell attachment quality. Real-time, continuous measurement ensures the documentation of cell phenotypes in the fo

New Company offers researchers a single genomic services resource with expanded global capabilities.